Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma

MeSH terms

• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Carcinoma, Renal Cell / drug therapy*
• Carcinoma, Renal Cell / pathology
• Carcinoma, Renal Cell / surgery
• Cell Dedifferentiation
• Combined Modality Therapy
• Female
• Humans
• Hypothyroidism / chemically induced
• Indoles / adverse effects
• Indoles / therapeutic use*
• Kidney Neoplasms / drug therapy*
• Kidney Neoplasms / pathology
• Kidney Neoplasms / surgery
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / secondary*
• Middle Aged
• Nephrectomy / methods
• Peripheral Nervous System Diseases / chemically induced
• Protein Kinase Inhibitors / adverse effects
• Protein Kinase Inhibitors / therapeutic use*
• Pyrroles / adverse effects
• Pyrroles / therapeutic use*
• Remission Induction
• Rhabdoid Tumor / drug therapy*
• Rhabdoid Tumor / pathology
• Rhabdoid Tumor / secondary*
• Rhabdoid Tumor / surgery
• Sunitinib